Astellas Pharma, Inc. earnings per share and revenue

ALPMY earnings per share for the last quarter are -0.12 USD whereas the estimation was -0.02 USD which accounts for -519.34% surprise. Företagets omsättning för samma period uppgår till 2.64 B USD trots den uppskattade siffran 2.49 B USD. Estimated earnings per share for the next quarter are 0.06 USD, and revenue is expected to reach 2.60 B USD. Also watch annual changes over time to get a bigger picture of ALPMY earnings per share and revenue dynamics.